GlassScriptPhysician profile
Ryan Stephenson Rowland
NPI 1740542034
$13,733.56
in general payments reported to CMS, 2019-2025
21 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $1,487 · 2021: $3,654 · 2022: $4,153 · 2023: $458 · 2024: $2,106 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,669 · Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,669.46 |
| Food and Beverage | $1,225.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,218.03 | 2021-2022 | |
| Stryker Corporation | $3,965.09 | 2019-2025 | Mako, Gamma, Insignia |
| Rattan and Associates | $2,161.02 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,592.09 | 2019-2023 | Persona |
| Depuy Synthes Sales INC. | $838.53 | 2019-2023 | Monovisc |
| Heraeus Medical, LLC. | $217.81 | 2019-2023 | Palacos |
| Smith+Nephew, INC. | $186.11 | 2019-2025 | Spatial Frame, Bioinductive Implant With Arthroscopic Delivery System - Medium, Rf20000 |
| Horizon Therapeutics Plc | $151.19 | 2019-2022 | |
| Bioventus LLC | $95.82 | 2019-2022 | |
| Pacira Therapeutics, INC. | $82.78 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $35.54 | 2020-2022 | |
| Vericel Corporation | $31.42 | 2021-2024 | Maci |
| Orthofix Medical, INC. | $25.99 | 2024-2025 | Physio-Stim |
| Pylant Medical | $24.18 | 2022 | |
| Fx Shoulder Solutions, INC | $22.71 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $16.73 | 2020 | |
| Assertio Therapeutics, INC. | $16.05 | 2020 | |
| Tactile Systems Technology INC | $15.54 | 2020 | |
| Ferring Pharmaceuticals INC. | $13.87 | 2019 | |
| Merck Sharp & Dohme LLC | $11.68 | 2022 | |
| Radius Health, INC. | $11.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rowland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.